European Immunology M&A Flares Up As Big Pharma Seeks Next Blockbuster – Ali Pashazadeh, Treehill’s CEO gives key insights for article in Mergermarket’s Snapshot series. 

Ali Pashazadeh, Treehill’s CEO, contributes to an article in Mergermarket summarising current trends in the European immunology, inflammatory and autoimmune marketplaces, including the current trends in M&A. This results from the in-depth interview between Ali and Jon Smith, leading life science Mergermarket reporter. 

Acuris is a widely renown financial news and data firm known for its products Mergermarket, a specialist in M&A intelligence, and Debtwire. It is owned by ION Investment Group, a financial software and data business which also owns Fidessa and Dealogic.

Read on for the full article at:

https://mergermarket.ionanalytics.com/content/1003960658